Angiotensin receptor blockers: are they related to lung cancer?


INTRODUCTION Angiotensin receptor blockers (ARBs) are commonly used antihypertensive medication with several other additional proven benefits. Recent controversy on association of lung cancer and other solid malignancy with the use of ARBs is concerning, although the follow-up studies have shown no such association. METHODS We used data from the… (More)
DOI: 10.1097/HJH.0b013e3283621ea3



Citations per Year

Citation Velocity: 9

Averaging 9 citations per year over the last 3 years.

Learn more about how we calculate this metric in our FAQ.

Cite this paper

@article{Rao2013AngiotensinRB, title={Angiotensin receptor blockers: are they related to lung cancer?}, author={Gowtham Adamane Rao and Joshua R Mann and Azza Shoaibi and Sachin Gopalakrishna Pai and Matteo Bottai and Shawn Scott Sutton and Kathlyn Sue Haddock and Charles L. Bennett and James R. H{\'e}bert}, journal={Journal of hypertension}, year={2013}, volume={31 8}, pages={1669-75} }